Holen Sie sich die Stockscreener-App
4.6097
0.43%
0.0197
Schlusskurs vom Vortag:
$4.59
Offen:
$4.64
24-Stunden-Volumen:
34,507
Relative Volume:
0.20
Marktkapitalisierung:
$49.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.25M
KGV:
-2.5897
EPS:
-1.78
Netto-Cashflow:
$-17.87M
1W Leistung:
+14.67%
1M Leistung:
+13.82%
6M Leistung:
+56.79%
1J Leistung:
+30.59%
1-Tages-Spanne:
$4.55
$4.6891
1-Wochen-Bereich:
$3.8907
$4.7034
52-Wochen-Spanne:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Firmenname
Lantern Pharma Inc
Sektor
Branche
Telefon
972-277-1136
Adresse
1920 MCKINNEY AVENUE, DALLAS, TX
Vergleichen Sie LTRN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
4.6266 | 49.57M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.58 | 107.98B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.65 | 59.07B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.60 | 59.76B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
804.51 | 49.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
337.29 | 38.56B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-07 | Eingeleitet | H.C. Wainwright | Buy |
Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten
Visual analytics tools that track Lantern Pharma Inc. performanceJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
Trend analysis for Lantern Pharma Inc. this weekShort Setup & Weekly High Conviction Trade Ideas - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Marco Eagle
Why Lantern Pharma Inc. is moving todayProfit Target & Technical Pattern Based Signals - newser.com
Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Real-Time Volume Triggers - newser.com
Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Movers & Real-Time Volume Analysis - newser.com
What’s the recovery path for long term holders of Lantern Pharma Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Lantern Pharma Inc. stock prediction for this weekEarnings Trend Report & Daily Profit Maximizing Tips - newser.com
Is Lantern Pharma Inc. showing signs of accumulation2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Lantern Pharma Inc.’s volatility index tracking explainedJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
What analysts say about Lantern Pharma Inc stockBullish Engulfing Patterns & Backtest Your Strategy Before You Risk Money - earlytimes.in
Is Lantern Pharma Inc a good long term investmentDividend Aristocrats List & Affordable Portfolio Building - earlytimes.in
FDA Guidance Advances Lantern Pharma's Pediatric Brain Cancer Therapy Toward 2026 Clinical Trial - citybuzz
Two stocks to invest in the future of pharma | 2025-09-29 | Investing News - Stockhouse
What drives Lantern Pharma Inc stock priceEconomic Indicators Overview & Small Budget Capital Investment - earlytimes.in
Lantern Pharma Holds Annual Stockholders Meeting - TipRanks
Lantern Pharma shareholders elect directors and approve stock option repricing - Investing.com
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):